| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 130,000 | 09 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ITOS | iTeos Therapeutics, Inc. | 09 Mar 2023 | 1 | $0 | 4 | Chief Medical Officer | 10 Mar 2023, 18:53 |
| ITOS | iTeos Therapeutics, Inc. | 11 Mar 2022 | 4 | -$110,985 | 4 | Chief Medical Officer | 14 Mar 2022, 20:01 |
| ITOS | iTeos Therapeutics, Inc. | 11 Feb 2022 | 4 | -$110,408 | 4 | Chief Medical Officer | 14 Feb 2022, 18:59 |
| ITOS | iTeos Therapeutics, Inc. | 14 Jan 2022 | 4 | -$122,564 | 4 | Chief Medical Officer | 18 Jan 2022, 19:02 |
| ITOS | iTeos Therapeutics, Inc. | 03 Jan 2022 | 3 | -$333,200 | 4 | Chief Medical Officer | 04 Jan 2022, 20:42 |
| ITOS | iTeos Therapeutics, Inc. | 17 Dec 2021 | 3 | -$256,900 | 4 | Chief Medical Officer | 17 Dec 2021, 18:59 |
| ITOS | iTeos Therapeutics, Inc. | 10 Dec 2021 | 3 | -$105,700 | 4 | Chief Medical Officer | 10 Dec 2021, 18:59 |
| ITOS | iTeos Therapeutics, Inc. | 18 Nov 2021 | 3 | -$845,600 | 4 | Chief Medical Officer | 19 Nov 2021, 19:00 |
| ITOS | iTeos Therapeutics, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Chief Medical Officer | 25 Jun 2021, 20:00 |